Related Experiment Video
Updated: Jan 14, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Loading causes molecular damage in fibrin fibers
Sajjad Norouzi1, Matthew J Lohr1, Mayar T Ibrahim1
1Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA. sajjadnorouzi@utexas.edu.
Abstract:
Blood clots are the body's natural biomaterials formed during wound healing, but they are also the cause of many pathologies, such as ischemic stroke. Fibrin, the main protein in clots, provides clots with mechanical strength through a network of fibrin fibers. These fibers exhibit high extensibility and primarily elastic properties under static loading conditions though little is known about single fiber mechanics under dynamic loading, as experienced in vivo. Indeed, many biological materials show distinct mechanical responses under repeated loading/unloading (cyclic loading), a prime example of which is clot embolization. Using lateral force microscopy, we show that fibrin fibers exhibit viscoelasticity and undergo irreversible molecular damage under cyclic loading. Cross-linking results in a more rigid structure with permanent damage occurring at larger strains - findings corroborated by computational modeling. Molecular spectroscopy analysis with broadband Raman scattering spectroscopy, combined with molecular dynamics simulations, allows identification of the damage source, unfolding pattern, and inter- and intramolecular changes in fibrin. The results reveal partial recovery of the protein's secondary and tertiary structures, providing a deeper understanding of fibrin's molecular wear under load and its behavior in wound healing and pathologies like stroke and embolism.
Related Concept Videos
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Intracellular Signaling Affects Focal Adhesions
Some...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

